New MS Remedies – What's Coming Down The Pipeline?

To start with, read more about MS and its treatments here: watch it

MS is a rare sort of diseases that a person can be diagnosed with. Although there is no such thing as a known treatment for this disease, there was an unbelievable amount of analysis in recent years to try to find a treatment that may assist relieve the symptoms and slow down the progression of this disease. Due to all the analysis being done there are several new MS treatment that can soon be available.

From Biogen Comes Tysabri

Relating to new MS treatment Biogen has been at the forefront. Their latest offering in the battle on multiple sclerosis is the drug Tysabri. Preliminary tests have been very positive. An independent research followed the circumstances of 23 sufferers that were given a total of 30 doses over a prescribed period of time after which the treatment was stopped. After a period of 14 months every affected person was subjected to CSF testing, MRI scans and quite a lot of other exams to see how they have been doing. The end test results showed that the majority of those sufferers had no relapses and showed no new signs of the disease in any of the testing.

Continue reading on a related subject: Good article!

Merck Jump The Queue With Cladribine

One of the world leaders in pharmaceuticals, Merck has introduced considered one of hottest new MS treatments already in the hands of the FDA for approval. As a substitute of being an old drug being examined for a brand new purpose, this can be a purpose designed medication. In their latest round of scientific tests involving two separate doses the results have been found to be among the many best of any new treatment on the market. The lower dose was truly more successful with a 58 % reduction in the number of annual relapses.

The higher dose only showed a fifty five % reduction in annual relapses when both results have been compared to these in the test group who got a placebo. In all the different independent tests the commonest unintended effects were headaches and nasopharyngitis. There is a small risk of cancer in some sufferers and it's hoped that this is not going to decelerate FDA approval of this potentially highly successful drug.

These new MS therapies hold out lots of hope to the tens of millions of people who suffer from multiple sclerosis. The number of therapies which have come before may have helped many sufferers to deal with the symptoms of the disease or slowed down its progression, but the vast majority of them had some potentially dramatic side effects. These new drugs are both designed to be taken orally and have limited side effects. This may be the first series of medications that can assist the disease with out the cure being almost worse than the disease, only time will tell.